PanThera CryoSolutions designs and manufactures cryopreservation solutions. The firm allows for the use of less expensive storage and transportation methods, restricting the usage of liquid nitrogen in some cell treatment applications. Their objective is to use their scientific expertise to create evidence-based products that limit ice crystal formation and protect cells, tissues, and organs from freezing damage while also lowering toxicity, enhancing stability, and improving post-thaw performance.
Something looks off?